Theory Financial LLC Abbott Laboratories Transaction History

Theory Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$90.19 - $110.4 $40,314 - $49,348	-447 Reduced 12.28%	3,194 $351,000
Q2 2023 Aug 07, 2023	SELL	$100.78 - $112.29 $10,078 - $11,229	-100 Reduced 2.67%	3,641 $396,000
Q4 2022 Feb 07, 2023	BUY	$95.06 - $111.52 $9,506 - $11,152	100 Added 2.75%	3,741 $410,000
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $420,644 - $515,055	3,641 New	3,641 $512,000

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Theory Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Theory Financial LLC with notifications on news.